Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Biotechnology
US: News
US Economy
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Business
Science
Alzheimer's disease
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Health care industry
Eisai Co Ltd
Eli Lilly and Co
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
AC Immune (ACIU)
Alzheimer's Disease
Breast Cancer
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Parkinson's Disease
Biogen Idec (BIIB)
metformin
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
influenza
Biogen Idec (BIIB)
Merck (MRK)
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
why it's moving
RHHBY
Market News
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Alzheimer's disease
Health
Local food
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
Cannabis
Market News
Markets
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
Biogen Idec (BIIB)
Roche (RHHBF RHHBY)
Amylx Pharmaceuticals (AMLX)
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
ABOS
ACIU
Small Cap
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
FDA
General
Biotech
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
Impax Laboratories (IPXL)
Rheumatoid Arthritis
Johnson and Johnson (JNJ)
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
Health & Healthcare
Research, Reports & Publications
Dr Pat Alagia
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
General
CGTX
Market News
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
ProMIS Neurosciences (PMN/TO ARFXF)
Genting Berhad (GEBHY)
TauRX Pharmaceuticals
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
Health Care
ABBV
News
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
Cassava Sciences (SAVA)
Guest Articles
TauRX Pharmaceuticals
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
Market News
BIIB
General
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
Biogen Idec (BIIB)
BACE Inhibitors
inflammation
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
ESALF
Alzheimer's disease
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Market News
why it's moving
Health Care
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
Market News
Phase 2 Trial
LGVN
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
General
Government
Biotech
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
General
Benzinga
Alzheimer's disease
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
News
ESALF
Health Care
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Market News
General
BIIB
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
Market News
Parkinson’s Disease
Preclinical Phase
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
General
Benzinga
Alzheimer's disease
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
News
Briefs
Biotech
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.